Unknown NA INTERVENTIONAL 2-arm NCT03673163

Lidocaine Infusion for Pain After Herniotomy (LIPAH)

Lidocaine Infusion for Pain After Herniotomy (LIPAH), A Randomized Placebo-controlled Trial (LIPAH Trial)

Sponsor: Guangzhou First People's Hospital

Conditions Chronic Pain Hernia, Inguinal Lidocaine Pain, Postoperative

Updated 6 times since 2018 Last updated: Nov 5, 2018 Started: Nov 6, 2018 Primary completion: Jun 30, 2019 Completion: Jun 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03673163, this NA trial focuses on Chronic Pain and Hernia, Inguinal and remains ongoing. Sponsored by Guangzhou First People's Hospital, it has been updated 6 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Dec 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Dec 2018 — Dec 2020 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Oct 2018 — Dec 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Guangzhou First People's Hospital

Data source: Guangzhou First People's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China